Downtown San Francisco Trolley

Earli Clinical Trial

in Australia

With your help, in the future, millions of people around the world could be diagnosed and treated for cancer earlier. Earli’s technology is designed to force small tumors to reveal themselves through a new biomarker detectable in a blood sample. The earlier, the better.

About the trial in
Australia

This innovative technology, created at Stanford University in the US, is now being tested in Australia for the first time at the Chris O’Brien Lifehouse (Sydney), the Olivia Newton-John Cancer Centre (Melbourne), at PASO (Frankston), and ICON Cancer Centre (Adelaide).

Who can participate?

You must be over 18 with confirmed locally advanced or metastatic lung cancer, or another cancer that has metastases in the lung or liver. You cannot have begun treatment or must be off previous treatments for at least 30 days. You must live in Australia.

You can find detailed criteria and contact information below in the official Australian New Zealand Clinical Trials Registry here:

Show Trial Details and Contact

How it works

Earli’s Chief Scientific Officer Dr David Suhy explains the purpose and background of the clinical trial.

How the trial process works:

You get one injection with the investigational drug.

You return to the clinic 4 times in the first 2 weeks to get blood drawn and assess how you are feeling.

You return at 30 and 60 days for the same process.

Eligible participants may be reimbursed for their time.

You get one injection with the investigational drug.

You return to the clinic 4 times in the first 2 weeks to get blood drawn and assess how you are feeling.

You return at 30 and 60 days for the same process.

Eligible participants may be reimbursed for their time.

Importantly, there will be little or no delay in your cancer treatment.

Thank you for considering supporting this trial.

ABOUT EARLI

StoryAdvisorsFoundersInvestors

Read More

Our BlogPrivacy Policy

cONTACT

Join the TeamClinical TrialContact
Earli Logo
© 2021 Earli Inc.All rights reserved